At Close: 4:00 PM
After Market: 10:50 PM
PFE Stock Price Today
Pfizer Inc. (PFE) stock declined over -0.24% intraday to trade at $44.055 a share on NYSE. The stock opened with a gain of 0.44% at $44.355 and touched an intraday high of $44.39, falling -0.24% against the last close of $44.16. The Pfizer Inc. in stock market went to a low of $43.88 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue$101.28 Billion
5Y Sales Change9.00%
Fiscal Year EndsDec. 2021
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Frequently Asked Questions
What is the current Pfizer Inc. (PFE) stock price?
Pfizer Inc. (NYSE: PFE) stock price is $44.05 in the last trading session. During the trading session, PFE stock reached the peak price of $44.39 while $43.88 was the lowest point it dropped to. The percentage change in PFE stock occurred in the recent session was -0.24% while the dollar amount for the price change in PFE stock was -$0.1.
PFE's industry and sector of operation?
The NYSE listed PFE is part of Pharmaceuticals industry that operates in the broader Health Care sector. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Who are the executives of PFE?
Ms. Angela Hwang
Group Pres of Biopharmaceuticals Group
Dr. Albert Bourla D.V.M., DVM, Ph.D.
Chairman & CEO
Mr. Frank A. D'Amelio
CFO & Exec. VP
Dr. Mikael Dolsten M.D., Ph.D.
Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical
How PFE did perform over past 52-week?
PFE's closing price is 0.06% higher than its 52-week low of $41.45 where as its distance from 52-week high of $56.32 is -0.22%.
How many employees does PFE have?
Number of PFE employees currently stands at 79,000. PFE operates from 235 East 42nd Street, New York, NY 10017, United States.
Link for PFE official website?
Official Website of PFE is: https://www.pfizer.com
How do I contact PFE?
How many shares of PFE are traded daily?
PFE stock volume for the day was 19,169,954 shares. The average number of PFE shares traded daily for last 3 months was 22.07 Million.
What is the market cap of PFE currently?
The market value of PFE currently stands at $249.92 Billion with its latest stock price at $44.05 and 5.61 Billion of its shares outstanding.